Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction

Heart and Vessels

Volumn 26, Issue 3, 2011, Pages 313-320

  Maréchaux, Sylvestre ^a   Six Carpentier, Marie M ^a   Bouabdallaoui, Nadia ^a   Montaigne, David ^a   Bauchart, Jean Jacques ^a   Mouquet, Frédéric ^a   Auffray, Jean Luc ^a   Le Tourneau, Thierry ^a   Asseman, Philippe ^a   Lejemtel, Thierry H ^b   Ennezat, Pierre Vladimir ^a,c  

^a UNIV LILLE   (France)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cardiology Hospital   (France)

Author keywords

Anemia; Heart failure; Kidney disease; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN;

ACUTE HEART FAILURE; ADULT; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT ATRIUM; HEART LEFT ATRIUM AREA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE END DIASTOLIC DIAMETER; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; KIDNEY DYSFUNCTION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 79959728229     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0057-5     Document Type: Article

References (51)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251-259 (Pubitemid 44079340)
2. Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H (2008) BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 10:252-259 (Pubitemid 351343862)
3. Brucks S, Little WC, Chao T, Rideman RL, Upadhya B, Wesley-Farrington D, Sane DC (2004) Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 93:1055-1057 (Pubitemid 38479469)
4. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL (2008) Anemia and heart failure: a community study. Am J Med 121:726-732
5. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG (2006) Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113:2713-2723 (Pubitemid 43947989)
6. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671-678
7. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM (2005) Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 111:1270-1277 (Pubitemid 40389091)
8. Tribouilloy C, Rusinaru D, Mahjoub H, Tartiere JM, Kesri-Tartiere L, Godard S, Peltier M (2008) Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94:1450-1455
9. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL (2008) Death in heart failure: a community perspective. Circ Heart Fail 1:91-97
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463 (Pubitemid 41821197)
13. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165-193
14. Sorrell VL, Reeves WC (2001) Noninvasive right and left heart catheterization: taking the echo lab beyond an image-only laboratory. Echocardiography 18:31-41 (Pubitemid 32171687)
15. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J, Phillips RA, Steingart R, Brown EJ Jr, Berkowitz R, Moskowitz R, Soni A, Mancini D, Bijou R, Sehhat K, Varshneya N, Kukin M, Katz SD, Sleeper LA, Le Jemtel TH (2004) Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43:1432-1438 (Pubitemid 38496351)
16. Tribouilloy C, Rusinaru D, Mahjoub H, Souliere V, Levy F, Peltier M, Slama M, Massy Z (2008) Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 29:339-347 (Pubitemid 351197754)
17. Anand IS (2008) Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52:501-511
18. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA (2006) Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 113:986-994 (Pubitemid 43879474)
19. Ueno H, Nakayama M, Kojima S, Kusuhara K, Nagayoshi Y, Yamamuro M, Nishijima T, Usuku H, Kaikita K, Sumida H, Yamabe H, Sugiyama S, Yoshimura M, Ogawa H (2008) The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events. Heart Vessels 23:243-248
20. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, the IPI (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456-2467
21. van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112:1743-1747 (Pubitemid 41368150)
22. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109:1004-1009 (Pubitemid 38282853)
23. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422-430 (Pubitemid 47179911)
24. Ho K, Pinsky J, Kannel W, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22:6A-13A
25. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61-67 (Pubitemid 38045917)
26. Kirkpatrick JN, Vannan MA, Narula J, Lang RM (2007) Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 50:381-396 (Pubitemid 47088124)
27. Yu CM, Sanderson JE, Marwick TH, Oh JK (2007) Tissue Doppler imaging: a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49:1903-1914 (Pubitemid 46711162)
28. Ennezat PV, Logeart D, Berrebi A, Vincentelli A, Maréchaux S (2010) Key role of Doppler echocardiography in the emergency management of elderly patients. Arch Cardiovasc Dis 103:115-128
29. Ennezat PV, Marechaux S, Huerre C, Deklunder G, Asseman P, Jude B, Van Belle E, Mouquet F, Bauters C, Lamblin N, Lejemtel TH, de Groote P (2008) Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J 155:752-757
30. Abramson SV, Burke JF, Kelly JJ Jr, Kitchen JG 3rd, Dougherty MJ, Yih DF, McGeehin FC 3rd, Shuck JW, Phiambolis TP (1992) Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116:888-895 (Pubitemid 23034779)
31. Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Imparato A, Corra U, Galli M, Giordano A (1996) Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 28:383-390 (Pubitemid 26274332)
32. Akioka K, Takeuchi K, Yanagi S, Hirota K, Sakamoto K, Yoshimura T, Toda I, Yoshikawa J (2000) Prognostic value of Doppler transmittal flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute decompensation. Heart Vessels 15:53-60 (Pubitemid 32042347)
33. Yamamoto T, Oki T, Yamada H, Tanaka H, Ishimoto T, Wakatsuki T, Tabata T, Ito S (2003) Prognostic value of the atrial systolic mitral annular motion velocity in patients with left ventricular systolic dysfunction. J Am Soc Echocardiogr 16:333-339 (Pubitemid 36397603)
34. Oh JK, Hatle L, Tajik AJ, Little WC (2006) Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47:500-506 (Pubitemid 43170836)
35. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115:1982-1990 (Pubitemid 46625948)
36. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424-1433 (Pubitemid 43739439)
37. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572-580 (Pubitemid 40171239)
38. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 52:347-356 (Pubitemid 352005813)
39. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725-2736 (Pubitemid 44729876)
40. Nishimura RA, Jaber W (2007) Understanding "diastolic heart failure:" the tip of the iceberg. J Am Coll Cardiol 49:695-697
41. Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D (2005) Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 11:177-187 (Pubitemid 40462419)
42. Burkhoff D, Maurer MS, Packer M (2003) Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 107:656-658
43. Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953-1959
44. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, Herrington DM, Link KM, Little WC (2001) Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38:796-802 (Pubitemid 32835755)
45. Kawaguchi M, Hay I, Fetics B, Kass DA (2003) Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107:714-720 (Pubitemid 36222599)
46. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288:2144-2150 (Pubitemid 35265382)
47. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ (1991) Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17:1065-1072
48. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA (2006) Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114:2138-2147 (Pubitemid 44747894)
49. Ennezat PV, Lefetz Y, Marechaux S, Six-Carpentier M, Deklunder G, Montaigne D, Bauchart JJ, Mounier-Vehier C, Jude B, Neviere R, Bauters C, Asseman P, de Groote P, Lejemtel TH (2008) Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail 14:475-480
50. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial. Lancet 362:777-781 (Pubitemid 37093918)
51. Lang CC, Mancini DM (2007) Non-cardiac comorbidities in chronic heart failure. Heart 93:665-671 (Pubitemid 46808262)